CLEO DIAGNOSTICS LTD

ASX: COV

Sector: Sector:Health Care
Industry group: Industry:Pharmaceuticals, Biotechnology & Life Sciences

Latest COV ASX Announcements

30 Sept 2026 · 8:52 amCompany Update
Cleo Files Patents for its Ovarian Cancer Screening Test
30 Sept 20268:52 amCleo Files Patents for its Ovarian Cancer Screening TestCompany Update
24 Sept 2026 · 9:09 amCompany Update
CLEO Commences Ovarian Cancer Screening Test Development
24 Sept 20269:09 amCLEO Commences Ovarian Cancer Screening Test DevelopmentCompany Update
17 Sept 2026 · 10:18 amMeetings & Governance
Letter to Shareholders
17 Sept 202610:18 amLetter to ShareholdersMeetings & Governance
17 Sept 2026 · 10:14 amMeetings & Governance
Notice of Annual General Meeting/Proxy Form
17 Sept 202610:14 amNotice of Annual General Meeting/Proxy FormMeetings & Governance
10 Sept 2026 · 5:01 pmMeetings & Governance
Notice Required Under ASX Listing Rule 3.13.1
10 Sept 20265:01 pmNotice Required Under ASX Listing Rule 3.13.1Meetings & Governance
10 Sept 2026 · 9:14 amCompany Update
CLIA Certified Lab selected - Pivotal US Clinical Validation
10 Sept 20269:14 amCLIA Certified Lab selected - Pivotal US Clinical ValidationCompany Update
3 Sept 2026 · 8:55 amCompany Update
CLEO Receives First Batch of Commercial Test Kits
3 Sept 20268:55 amCLEO Receives First Batch of Commercial Test KitsCompany Update
24 Aug 2026 · 4:33 pmDirector Interests
Change of Director's Interest Notice x 4
24 Aug 20264:33 pmChange of Director's Interest Notice x 4Director Interests
24 Aug 2026 · 4:16 pmSecurities Administration
Cleansing Notice
24 Aug 20264:16 pmCleansing NoticeSecurities Administration
24 Aug 2026 · 4:14 pmSecurities Administration
Application for quotation of securities - COV
24 Aug 20264:14 pmApplication for quotation of securities - COVSecurities Administration
24 Aug 2026 · 4:12 pmSecurities Administration
Notification of cessation of securities - COV
24 Aug 20264:12 pmNotification of cessation of securities - COVSecurities Administration
21 Aug 2026 · 4:22 pmDirector Interests
Change in Director's Interest Notice
21 Aug 20264:22 pmChange in Director's Interest NoticeDirector Interests
20 Aug 2026 · 4:01 pmCompany Administration
Appendix 4G and Corporate Governance Statement
20 Aug 20264:01 pmAppendix 4G and Corporate Governance StatementCompany Administration
20 Aug 2026 · 3:52 pmFinancial Results
Appendix 4E and 2026 Annual Report
20 Aug 20263:52 pmAppendix 4E and 2026 Annual ReportFinancial Results
29 July 2026 · 9:39 amQuarterly Reports
Quarterly activities and cashflow report
29 July 20269:39 amQuarterly activities and cashflow reportQuarterly Reports

View complete COV announcement history →